Compositions, methods and kits related to thrombin, Notch signaling and stamatogenesis and growth of stem cells
The present invention relates to methods based on the interactions of thrombin as a biological regulator. More specifically, the invention relates to the interactions of thrombin with regard to Notch signaling, Jagged1, PAR1, and cellular effects mediated thereby. The invention relates to the discovery that thrombin cleaves Jagged1 to produce non-membrane soluble Jagged1 (sJ1). The soluble Jagged1 protein can affect Notch signaling and, among other things, mediate the release of FGF-1 and/or IL-1α from a cell. The invention further relates to the role(s) of thrombin and signaling via Notch proteins and the effect on thrombosis, angiogenesis, and/or differentiation, among other processes. Moreover, the invention relates to discovery that thrombin, sJ1, and TRAP mediate, inter alia, rapid non-classical release of FGF-1, and proteins associated therewith (e.g., p40 Syn1 and S100A13, among others), and the effect growth and proliferation of a stem cell without loss of differentiation potential. Thus, the present invention relates to methods of clonally expanding a pluripotent stem cell while preserving the differentiation potential of the cell, a process termed “stamatogenesis.”
1. A method for producing a population of pluripotent stem cells, said method comprising expanding a stem cell wherein said cell is contacted with an effective amount of a factor selected from the group consisting of thrombin, soluble Jagged1 (sJ1), and thrombin receptor-activated peptide (TRAP), and combinations thereof, thereby producing a population of pluripotent stem cells, wherein said stem cell is selected from the group consisting of a neural stem cell and a neural crest stem cell.
2. A method for obtaining a clonally expanded stem cell, said method comprising obtaining a stem cell from a human, administering a differentiation inhibiting amount of at least one inhibitor of Notch-signaling selected from the group consisting of thrombin, soluble Jagged 1 (sJ1), and thrombin receptor-activated peptide (TRAP) to said stem cell; allowing said cell to proliferates, thereby obtaining a clonally expanded stem cell, wherein said stem cell is selected from the group consisting of a neural stem cell and a neural crest stem cell.
3. A method for expanding a multipotent stem cell without detectable loss of multipotentiality, said method comprising growing a multipotent stem cell wherein said cell is contacted with a differentiation inhibiting amount of thrombin, thereby expanding a multipotent stem cell without detectable loss of multipotentiality, wherein said stem cell is selected from the group consisting of a neural stem cell and a neural crest stem cell.
4. The method of claim 3 , further comprising contacting said cell with a differentiation inhibiting amount of sJ1.
5. The method of claim 4 , said method further comprising contacting said cell with a differentiation inhibiting amount of TRAP.
6. The method of claim 3 , said method further comprising contacting said cell with a differentiation inhibiting amount of TRAP.
7. A kit for producing a population of pluripotent stem cells, without detectable loss of pluripotency, said kit comprising an effective amount of thrombin, said kit further comprising sJ1, said kit further comprising an applicator and an instructional material for the use of said kit.
8. A kit for expanding a pluripotent stem cell without detectable loss of pluripotency, said kit comprising a differentiation inhibiting amount of thrombin, said kit further comprising thrombin receptor-activated peptide (TRAP), said kit further comprising an applicator and an instructional material for the use of said kit.